MEREO BIOPHARMA
Mereo is based in London and was founded in March 2015 to fund and develop novel, innovative specialist focused products from large pharmaceutical or biotechnology companies. Pharmaceutical companies face increasingly difficult choices in the allocation of internal resources to their drug development programs. With significant P&L constraints and rich pipelines it has become increasingly difficult for many companies to fully fund and advance development all of their drug candidates, especi... ally beyond Phase 2. Mereo has been formed to take advantage of the global pharmaceutical industry's drive for creative ways to progress their clinical development pipelines. Mereo has acquired an initial mid-late stage portfolio of three exceptionally well characterised novel products for the treatment of diseases with considerable unmet medical need from Novartis Pharmaceuticals. Each of these programmes has a comprehensive dataset for both pre-clinical and proof-of-concept clinical studies. Additional product opportunities are under evaluation. Mereo's focus is the development of innovative medicines that have the potential to significantly transform the lives of patients suffering from rare and other specialised conditions around the world. To do this, the Company depends on the combination of its team's expertise in selecting and acquiring product opportunities, creating value in the development pipeline and structuring creative transactions. Mereo's internal expertise is complemented by a unique partnership with a leading global CRO, ICON. Mereo combines the operational discipline and efficiency of a small company with the financial resources to conduct comprehensive clinical studies. Mereo will rapidly progress each of the products through further value inflection points before partnering or divesting its products. The Company also has the option to directly commercialise products, for example in orphan disease indications.
MEREO BIOPHARMA
Industry:
Biopharma Biotechnology Health Care Innovation Management
Founded:
2015-03-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.mereobiopharma.com
Total Employee:
11+
Status:
Active
Contact:
+4403330237300
Total Funding:
337.46 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Domain Not Resolving Mobile Non Scaleable Content Amazon
Similar Organizations
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
Touchlight Genetics
Touchlight Genetics, a British bio-pharmaceutical company founded in 2007.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Post-IPO Equity - Mereo Biopharma
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Mereo Biopharma
Commodore Capital
Commodore Capital investment in Post-IPO Equity - Mereo Biopharma
Pontifax
Pontifax investment in Post-IPO Equity - Mereo Biopharma
Janus Henderson Investors
Janus Henderson Investors investment in Post-IPO Equity - Mereo Biopharma
Aspire Capital Partners LLC
Aspire Capital Partners LLC investment in Post-IPO Equity - Mereo Biopharma
Tavistock Group
Tavistock Group investment in Post-IPO Equity - Mereo Biopharma
Vivo Capital
Vivo Capital investment in Post-IPO Equity - Mereo Biopharma
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - Mereo Biopharma
Boxer Capital
Boxer Capital investment in Post-IPO Equity - Mereo Biopharma
Key Employee Changes
Date | New article |
---|---|
2020-06-30 | Mereo BioPharma Appoints John Lewicki Chief Scientific Officer |
Official Site Inspections
http://www.mereobiopharma.com Semrush global rank: 2.51 M Semrush visits lastest month: 7.01 K
- Host name: 172.67.69.165
- IP address: 172.67.69.165
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago